Abstract | The Hippo pathway is a signalling cascade conserved from Drosophila melanogaster to mammals. The mammalian core kinase components comprise MST1 and MST2, SAV1, LATS1 and LATS2 and MOB1A and MOB1B. The transcriptional co-activators YAP1 and TAZ are the downstream effectors of the Hippo pathway and regulate target gene expression. Hippo signalling has crucial roles in the control of organ size, tissue homeostasis and regeneration, and dysregulation of the Hippo pathway can lead to uncontrolled cell growth and malignant transformation. Mammalian intestine consists of a stem cell compartment as well as differentiated cells, and its ability to regenerate rapidly after injury makes it an excellent model system to study tissue homeostasis, regeneration and tumorigenesis. Several studies have established the important role of the Hippo pathway in these processes. In addition, crosstalk between Hippo and other signalling pathways provides tight, yet versatile, regulation of tissue homeostasis. In this Review, we summarize studies on the role of the Hippo pathway in the intestine on these physiological processes and the underlying mechanisms responsible, and discuss future research directions and potential therapeutic strategies targeting Hippo signalling in intestinal disease.
The mammalian gastrointestinal tract is part of the digestive system responsible for food digestion and absorption. As a result of constant exposure to pathogens and xenobiotics, intestinal epithelial cells (IECs) have a short half-life, and have therefore evolved the ability to rapidly regenerate after damage. Intestinal regeneration is precisely controlled by a myriad of cellular signalling pathways and the crosstalk between them. The Hippo pathway plays a key part in cell-fate decision, tissue homeostasis and control of organ size by regulating cell proliferation, apoptosis and differentiation 1, 2 , and dysregu lation of this pathway has been associated with many human malignancies 3, 4 . In the past few years, studies have revealed the importance of the Hippo pathway in gastrointestinal tract physiology 5 . In this Review, we will focus on the role of the Hippo pathway in tissue homeostasis, regeneration and tumorigenesis in the small intestine and the colon. In addition, we will also briefly discuss the functional roles of the Hippo pathway in the liver.
Hippo pathway overview The Hippo pathway in Drosophila melanogaster
The Hippo pathway is mostly conserved between Drosophila melanogaster and mammals 6, 7 ; it was initially identified in Drosophila during screens for genes that negatively regulate tissue growth. Loss of the serine/threonine-protein kinase warts (Wts) resulted in organ overgrowth in Drosophila wing and eye 8, 9 . Similar genetic screens later identified that mutation of the Hippo kinase (Hpo) resulted in a similar tissue overgrowth phenotype [10] [11] [12] [13] [14] . In addition, the adaptor proteins salvador (Sav) and MOB kinase activator-like 1 (Mats) were found to be partners of Hpo and Wts, respectively, with similar mutation phenotypes [15] [16] [17] . Five proteins comprise the core of the Hippo pathway: the Hpo kinase and its binding partner Sav; the Wts kinase and its binding partner Mats; and the transcriptional co-activator yorkie (Yki). Yki mediates the main functional output of the Hippo pathway and binds to the transcription factor Scalloped (Sd), which induces the expression of genes that promote cell prolifer ation, for example cyclin E (CycE) and the bantam microRNA (miRNA), or genes that prevent apoptosis, for example death-associated inhibitor of apoptosis (Diap1) 18, 19 . The Hpo-Sav complex phosphoryl ates and activates the Wts-Mats complex [10] [11] [12] 14, 17, 20 , which in turn phosphoryl ates and inactivates Yki by sequestering Yki in the cytoplasm, thereby negatively regulating YkiSd interaction and Sd-mediated gene expression 21 . Three studies published between 2014 and 2015 show that, in addition to Hpo, two kinases known as Happyhour (Hppy) and Misshapen (Msn) also activate the Wts-Mats complex [22] [23] [24] . Overexpression of Yki or deletion of Hpo, Sav, Wts or Mats leads to overgrowth phenotypes in Drosophila eye, wing, midgut and other tissues as a result of increased cell proliferation and decreased apoptosis [10] [11] [12] 14, 25 .
The Hippo pathway in mammals
The Hippo pathway in mammals consists of the core components mammalian STE20-like protein kinase 1 and 2 (MST1 and MST2, homologues of Hpo, also known as serine/threonine-protein kinase 4 and 3, respectively), salvador homologue 1 (SAV1, a homologue of Sav), large tumour suppressor 1 and 2 (LATS1 and LATS2, homologues of Wts), MOB kinase activator 1A and 1B (MOB1A and MOB1B, homologues of Mats), and the two Yki homologues Yes-associated protein 1 (YAP1, also known as transcriptional co-activator YAP1) and transcriptional co-activator with PDZ-binding motif (TAZ, also known as WW domain-containing transcription regulator protein 1, WWTR1) 26 . YAP1 and TAZ have overlapping functions when they are expressed in the same cells 27 , but also have divergent functional roles in different organs as YAP1 and TAZ knockout mice show different developmental deficiencies 28 . MST1 and MST2 form homodimers via C-terminal Sav/RassF/Hpo (SARAH) domains, resulting in activation loop autophosphorylation [29] [30] [31] [32] . MST1 and MST2 can phosphorylate LATS1 and LATS2 at the hydrophobic motif to induce their activation. The scaffold proteins SAV1 and MOB1 are also phosphorylated and activated by MST1 and MST2; activated SAV1 and MOB1 promote LATS1 and LATS2 activity [33] [34] [35] . The Hppy homologues MAP4K1, MAP4K2, MAP4K3 and MAP4K5, and the Msn homologues MAP4K4, MAP4K6 and MAP4K7 act in parallel with MST1 and MST2 to phosphorylate the hydrophobic motifs of LATS1 and LATS2, thereby leading to their activation 22, 24 . Activated LATS1 and LATS2 in turn phosphorylate YAP1 and TAZ, leading to the retention of YAP1 and TAZ in the cytoplasm by 14-3-3 family proteins. Cytoplasmic YAP1 and TAZ can undergo further phosphorylation and ubiquitylation-dependent degradation 36, 37 , preventing their interaction with the mammalian homologues of Sd, transcriptional enhancer factor TEF-1 (also known TEA domain family member 1, TEAD1), TEAD2, TEAD3 and TEAD4. Because the YAP1-TEAD complex activates the transcription of genes involved in cell growth and survival, including CTGF, MYC and BIRC5 (also known as survivin), the degradation of YAP1 as a result of phosphorylation by LATS1 or LATS2 reduces expression of these genes 38, 39 . Loss-of-function mutation of the Hippo kinase cascade components in mammals, such as inactivation of Merlin (also known as NF2) and deletion of LATS2 in mesothelioma 40 , also leads to overgrowth phenotypes and consequently carcinogenesis in multiple tissues 3, 41 .
The regulatory signals of the Hippo pathway
The mammalian Hippo pathway responds to a variety of extracellular signals, including cell polarity, contact inhibition, stress, mechanotransduction, cell attachment, hormones and growth factors 7 . More than 20 upstream regulators of the Hippo pathway 42 have been discovered, many of which are involved in intestinal homeostasis and carcinogenesis (FIG. 1 ).
Polarity and cell-adherence signals.
Intestinal epithelial cells, which display apical-basal polarity, are joined together by tight junctions and adherens junctions, forming the intestinal epithelium layer. Intestinal diseases are often associated with disruption of IEC polarity or epithelial junctions 43 . The components of apical-basal polarity complexes attenuate the tran scription activities of YAP1 and TAZ. For instance, in addition to stimulating LATS kinase activity, Angiomotin (AMOT) family proteins can directly bind to YAP1 and TAZ, sequestering them at tight junctions and inhibiting their transcriptional activity 44, 45 . Studies in Drosophila have shown that the FERM (Four-point-one protein, ezrin, radixin and moesin) domain proteins Merlin and Expanded colocalize with Kibra at the apical domain of polarized epithelial cells to promote the activation of Wts by Hpo 46 . Many other key regulators of the Hippo pathway, such as α-catenin, tyrosine-protein phosphatase non-receptor type 14 (also known as PTPN14), and cadherin-1 (also known as E-cadherin), are also components of junction complexes, and attenuate YAP1 and TAZ transcriptional activity by either increasing the kinase activity of LATS or directly sequestering YAP1 and TAZ at cell junctions 26 . A study published in 2014 showed that LKB1, which is a master regulator of the development and maintenance of cell polarity, activates the Hippo pathway in human cell lines through its substrates, the serine/threonine-protein kinase MARK protein family and Scribble 49 . Another LKB1 substrate, 5ʹ-AMP-activated protein kinase (AMPK), directly phosphorylates YAP1, disrupting YAP1-TEAD interaction and inhibiting YAP1 transcriptional activity [50] [51] [52] . In Drosophila, the planar cell polarity proteins cadherinrelated tumour suppressor (also known as Fat) and Dachsous inactivate Yki by promoting the abundance and localization of Expanded at the apical membrane, thereby stimulating Wts activity [53] [54] [55] [56] . 36 . Hippo pathway signalling is required for contact inhibition of cell growth mediated by the E-cadherin-catenin complex 57 . In addition, overexpression of constitutively active YAP1 leads to loss of contact inhibition in epithelial cells 36 . Contact inhibition has been shown to control miRNA biogenesis through the Hippo pathway. High YAP1 activity in cancer cells, in part due to loss of contact inhibition, led to a global downregulation of miRNA synthesis and potentially enhanced tumorigenesis 58 . However, another study reported conflicting results 59 , showing that YAP1 and TAZ promote processing and biogenesis of miRNA in human cells cultured at low density without contact inhibition. By contrast, cells under high density experiencing contact inhibition showed defective processing of miRNAs owing to loss of YAP1 and TAZ activities 59 .
Regulation of Hippo signalling by stress. As a result of its physiological role in digestion, gastrointestinal tract tissue experiences many stresses, including oxidative stress, endoplasmic reticulum stress and hypoxia. These stresses regulate YAP1 and TAZ by various mechanisms [60] [61] [62] . In addition, YAP1 and TAZ transcriptional activities are also controlled by mechanical signals through Rho GTPases or JNK1/2 (REFS 63-65), although the involvement of the Hippo pathway in YAP1 and TAZ regulation in this context is still under debate 65, 66 . Mechanical forces affect many aspects of intestinal physio logy, particularly by promoting the proliferation and migration of gut epithelial cells 67 . However, whether YAP1 and TAZ play any part in the response of IECs to mechanical signals has not been studied.
G protein-coupled receptor regulation. Extracellular signalling molecules such as hormones can regulate the Hippo pathway via G protein-coupled receptors (GPCRs) [68] [69] [70] . GPCR overexpression or mutations of guanine nucleotide-binding protein subunit alpha (Gα) proteins have been associated with carcinogenesis in a variety of tissues 71 . Many GPCRs known to promote cell growth and tumorigenesis, such as lysophosphatidic acid receptors (LPARs), sphingosine 1-phosphate receptors (S1PRs) and protease-activated receptors (PARs), are now recognized as cell surface receptors for Hippo signalling 68, 70 , suggesting that the Hippo pathway mediates GPCR-induced tumorigenesis. Indeed, GPCRs coupled to Gα 12 or Gα 13 , or to Gα q/11 , can activate YAP1 and TAZ, leading to tumorigenesis [72] [73] [74] . On the other hand, Gα s activation was shown to inhibit YAP1 and TAZ 68, 75, 76 . Intestinal GPCRs respond to many nutrients and other components in food, and therefore play a crucial part in regulating intestine physiology, particularly in metabolic homeostasis and appetite 77 . It would be interesting to evaluate whether the Hippo pathway is regulated by GPCRs that are highly expressed in the intestine, for instance the GPCRs that respond to fatty acids (which include free fatty acid receptors and GPR120) 77 .
Intestinal regeneration and homeostasis
Hippo pathway in Drosophila midgut regeneration Drosophila has been widely recognized as a powerful and convenient animal model to study cellular mechanisms of human intestinal diseases, owing to its simple structure and well-defined cell populations 78 . The Drosophila gut consists of foregut, midgut and hindgut [81] [82] [83] [84] . These studies support the role of the Hippo pathway in regulating the autono mous prolifer ation of ISCs. Ren et al. 83 further showed that in addition to Upd, Yki also promotes the transcription of multiple Egfr ligands to promote non-autonomous proliferation of ISCs (FIG. 2) . Besides JNK and Jub, several other proteins play important parts in regulating Yki activities. Pez, the Drosophila homologue of PTPN14, negatively regulates Yki-mediated ISC proliferation by binding to Kibra, thereby activating the core Hippo pathway kinase cascade 85 . A later study showed that Pez protein stability is negatively regulated by E3 ubiquitin-protein ligase Su(dx) (also known as Su(dx)), a member of the Nedd4 family of E3 ubiquitin ligases, and overexpression of Su(dx) in enterocytes leads to Drosophila midgut epithelium proliferation 86 . Notably, mammalian PTPN14 has been reported to be highly mutated in human colorectal cancers (CRCs) 87 . Exploring the role of PTPN14 in CRCs and whether the Hippo pathway is involved in tumorigenesis would be interesting. In addition, Yki activity in Drosophila ISCs is attenuated by Tao, a protein kinase that activates Hpo, to maintain midgut homeostasis 88 . Msn, which seems to activate Wts preferentially in enteroblasts in a Hpo-independent manner, is involved in controlling ISC proliferation by inhibiting Upd3 expression during intestinal regeneration Yki target gene Diap1 is essential for Brahma to participate in ISC proliferation 90 . Future studies are needed to determine whether the mammalian homologues of these Hippo pathway regulators and effectors also have important roles in mammalian intestinal homeostasis.
The Hippo pathway in mammalian intestine
Intestine cellular structure. The functional unit of the mammalian small intestine is the villus, which contains a group of dynamic and self-renewing epithelial cells 91 . Between the villi are invaginations of the epithelium, called the crypts of Lieberkühn. The bottom of the crypt, where ISCs reside, is the main stem cell niche. These stem cells divide to produce highly proliferative transit amplifying cells, which migrate upwards to the tip of the villi and eventually lose their progenitor identity. While moving upwards, transit amplifying cells differentiate into either absorptive enterocytes or secretory cells, which comprise goblet cells, enteroendocrine cells and Paneth cells 91 . Unlike the goblet cells and enteroendocrine cells, which both reside within the villi, Paneth cells migrate towards the base of the crypt and reside beside the ISCs (FIG. 3) . Paneth cells are critical for stem cell maintenance as they secrete essential niche signal ligands such as epidermal growth factor (EGF), WNT3a and Notch ligand DLL4 (REF. 92 ). Although the cellular structure and organization of the colon is mostly similar to that of the small intestine, the colon has a flat surface of epithelia with no villi and no Paneth cells in the crypt 93 . A subpopulation of CD24 + cells, located adjacent to colonic stem cells in the colonic crypt, are proposed to provide the stem cell niche by functioning equivalently to Paneth cells 92 .
The base of the intestinal crypt is a specialized ISC niche harbouring two distinct stem cell populations, active stem cells and reserved stem cells. Active stem cells, called crypt base columnar (CBC) cells, express Leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5) 94 .
LGR5 + cells are evenly distributed between Paneth cells and are responsible for normal epithelial homeostasis. The identity of reserved stem cells is less clear. The proteins polycomb complex protein BMI1 (also known as BMI1), homeodomain-only protein (also known as HOPX), telomerase reverse transcriptase (also known as TERT), and Leucine-rich repeats and immunoglobulin-like domains protein 1 (also known as LRIG1) were proposed as markers for +4 reserved stem cells, which reside at the fourth position from the crypt base, but all were later reported to be also highly expressed in CBC cells 95 . Nonetheless, it is widely accepted that reserved stem cells are responsible for repopulating the entire tissue after injury 91, 96 . The turnover time of mouse intestinal epithelial cells is ~3-5 days 91 . This high rate of cellular turnover has evolved to maintain optimal intestinal function, and makes the intestine an attractive organ system for the study of cell proliferation, differentiation and regenerative medicine.
Role of the Hippo pathway in normal homeostasis. YAP1 and TAZ have been reported to maintain and promote stem cell properties in various tissues, such as the liver, skin and nervous system 97 . In the intestine, endogenous YAP1 protein expression is restricted to the stem cell niche at the bottom of the crypt, suggesting an association with ISC regulation [98] [99] [100] . Several studies have reported that high YAP1 activity can promote ISCs prolifer ation. Camargo et al. 98 and Zhou et al. 101 showed that YAP1 Nature Reviews | Gastroenterology & Hepatology overexpression in the intestine leads to expansion of undifferentiated cells and the replacement of differentiated cells at the tips of the villi, similar to the phenotype observed in intestines deficient in MST1 and MST2. In addition, using the intestine-specific gene transfer technique, YAP1 and TAZ were shown to promote proliferation of stem cells and progenitor cells by binding to TEAD transcription factors, and to induce differentiation of progenitor cells into goblet cells by binding to the transcription factor Krueppel-like factor 4 (KLF4) 102 . Under normal homeostasis, protein kinase C zeta type (PKCζ) acts as a tumour suppressor gene, suppressing YAP1 activity through direct phosphorylation in ISCs. Loss of PKCζ in the intestine increases YAP1 nuclear localization, leading to elevated stem cell activity and tumori genesis 103 . In general, YAP1 and TAZ activity promotes stem cell properties in the intestine. However, Barry et al. 104 showed that intestine-specific acute induction of YAP1 expression in mice results in disruption of normal intestinal tissues, such as mislocalized Paneth cells and reduced ISC numbers, resulting in loss of cellular proliferation in crypts. This finding suggests that YAP1 has a growthsuppressive function in healthy intestine. The inconsistency of these results with those of Camargo et al. 98 might be due to different experimental settings and mouse models. For example, mice with inducible systemic YAP1 over expression were used in the study by Camargo et al. 98 , whereas Barry et al. 104 induced YAP1 expression specifically in the IECs. IECs constantly interact with neighbouring stromal cells and immune cells, which might also regulate YAP1 by chemical or mechanical cues. Thus, the opposite prolifer ation phenotypes observed in the models could result from autonomous and non-autonomous effects. YAP1 cellular localization might also be different after systemic induction of expression compared with localization after intestine-specific induction. In contrast to the activation of Wnt signalling by nuclear YAP1, cytoplasmic YAP1 inhibits Wnt signalling, leading to opposite effects on progenitor cell preservation and proliferation 2 . Moreover, strong YAP1 induction also initiates negative feedback regulation by inducing LATS2 expression, which might exert some growth inhibitory effect [105] [106] [107] . The Hippo pathway is important in maintaining normal intestine homeostasis; disrupted Hippo signalling leads to tissue overgrowth and tumorigenesis. Mice with conditional knockout of Mst1 and Mst2 specifically in IECs show a disorganized villus structure and expansion of undifferentiated cells. Dysplastic epithelia and adenomas are frequently observed in the colons of these mice 101 . Similarly, mice with Sav1-deficient small and large intestines show enlarged crypt structure and increased polyp formation 100 . Surprisingly, various reports show that depletion of YAP1 and/or TAZ protein levels in the intestine has no observable adverse phenotype under normal homeostasis, meaning that YAP1 (REFS 98, 100, 104) and TAZ 99 might be dispensable under normal conditions. Conversely, the Hippo pathway components MST1, MST2 and SAV1 are indispensable for normal tissue homeostasis, suggesting that the Hippo pathway is constitutively active under normal conditions to restrict YAP1 and TAZ activity. Disruption of the Hippo pathway leads to hyperactivation of YAP1 and TAZ, which then causes uncontrolled stem cell proliferation and tumorigenesis 100, 101 . Currently, only mice with intestine-specific conditional knockout of Mst1 and Mst2, Sav1, and Yap1 and/or Taz have been studied, and further investigations could provide new mech anistic insights into how other Hippo pathway components regulate intestinal tissue homeostasis.
Role of the Hippo pathway in regeneration. Although YAP1 is not required during normal intestinal homeostasis, its activity is essential for intestinal regeneration after injury. In mice, an increase in YAP1 protein level is observed 2-5 days after dextran sulfate sodium (DSS)-induced colitis and regeneration 100, 108 . In vivo and in vitro studies show interleukin-6 receptor subunit beta (also known as gp130), a co-receptor for IL-6, activates YAP1 through Src family kinases (SFKs) upon DSS-induced intestinal colitis 108 . Mice with IEC-specific conditional knockout of Yap1 had a higher mortality rate and more extensive loss of the crypt compartment than wild-type mice after both groups were subjected to DSS-induced intestinal injury 100 . Whole-body irradiation is also widely used to study intestinal regeneration in mice. YAP1 is activated in IECs 2-4 days after irradiation 109 , and IECspecific and ISC-specific Yap1 knockout mice show reduced crypt proliferation after irradiation-induced injury 109 . These studies suggest that YAP1 positively regu lates intestinal tissue regeneration by regulating ISC proliferation. Furthermore, Gregorieff et al. 109 found that YAP1 reprogrammes ISCs by transiently inactivating Wnt signalling and activating another regenerative programme, the EGFR pathway. They showed that the EGFR ligand epiregulin is upregulated in the intestines of Yap1 conditional knockout mice after regeneration of the intestinal epithelia following whole-body exposure to ionizing radiation, which might serve as a compensatory mechanism for Yap1 loss in some crypts. Indeed, they further showed that exogenous epiregulin can rescue YAP1-deficient organoid formation ex vivo 109 . By contrast, Barry et al. 104 found that whole-body irradiation of mice with intestine-specific Yap1 conditional knockout resulted in crypt hyperplasia and overgrowth 7 days later, and suggested that Wnt signalling hyperactivation was responsible for this phenotype. In summary, functional YAP1 is important in the first few days of the regeneration phase. The hyperproliferative phase seen in Yap1-IECspecific conditional knockout mice 7 days after injury could be the result of enhanced Wnt signalling (FIG. 4) . The divergent roles of YAP1 in the regener ative response at different time points after injury might be due to the distinct cellular repair mechanisms activated at these time points. For instance, pathways involved in cell cycle and DNA repair are active 2-5 days after injury whereas pathways for tissue development might be activated at subsequent time points, 1 week or later after injury 110 . YAP1 and Wnt signalling work in coordination to maintain proper tissue regeneration after injuries. Mouse genetic studies clearly demonstrate a role of the Hippo pathway in normal intestine homeostasis as well as in the response to tissue injury.
The Hippo pathway and signalling crosstalk
Intestinal epithelial homeostasis is tightly controlled and regulated by interconnected developmental pathways that keep cellular processes such as proliferation and differentiation in balance. Several conserved signalling pathways, such as the Wnt, Notch, Hedgehog and bone morphogenetic protein (BMP) pathways, have been shown to regulate mammalian intestinal homeostasis and regeneration 111 . Understanding how the Hippo pathway interacts with these signalling pathways can help explain the phenotypes observed in mouse models with disrupted Hippo signalling, and will be beneficial for developing therapeutic strategies (FIG. 5) .
Hippo and Wnt signalling. Wnt signalling is essential for intestinal tissue homeostasis and stem cell maintenance 112 . Canonical Wnt signalling depends on β-catenin as its key effector. β-catenin binds to the TCF and LEF families of transcription factors to activate the transcription of target genes. Nuclear localization of β-catenin, which represents active Wnt signalling, has been observed in mice in the ISCs at the base of the crypt 113 . Also in mice, inhibition of canonical Wnt signalling results in loss of transit amplifying cells and disrupted crypt structure, leading to defects in intestinal homeostasis and function 114 . Interplay between the Hippo pathway and Wnt signalling has been intensively studied in the context of stem cell maintenance and damage repair. In the mammalian intestine, YAP1 maintains the prolifer ation and stemness of crypt stem cells by activating Wnt signalling pathways 98, 101 . YAP1 overexpression induces nuclear β-catenin accumulation and expression of β-catenin target genes 98 . In addition, the Wnt target genes and stem cell markers Lgr5 and Ascl2 are upregulated in the intestines of mice with intestine-specific conditional double knockout of Mst1 and Mst2 (REF. 101 ). In vitro studies show that downregulation of YAP1 in the SW480 human colon cancer cell line results in a decrease in β-catenin-dependent transcription 101 . These studies indicate that YAP1 activity potentiates Wnt signalling. On the other hand, several studies have shown that cytoplasmic YAP1 and TAZ inhibit canonical Wnt signalling, and several mechanisms have been proposed to explain this regulation. Firstly, cytoplasmic YAP1 and TAZ bind to segment polarity protein dishevelled homologue DVL-1 (known as DVL), a positive regulator of Wnt, and suppress its activity 104, 115 . Secondly, β-catenin nuclear translocation is supressed by direct binding with YAP1 and TAZ 116 ; and thirdly, YAP1 and TAZ incorporate into the β-catenin destruction complex to recruit F-box/WD repeat-containing protein 1A (also known as β-transducin repeat-containing protein, β-TrCP), which ubiquitylates β-catenin and leads to its degradation 99 . YAP1 overexpression in mice causes an increase in cytoplasmic YAP1 levels and downregulates intestinal β-catenin target gene expression 104 . Reciprocally, several studies have shown that YAP1 and TAZ can be activated by Wnt signalling, and are required for some Wnt responses in the intestine 99, 117, 118 . Notably, the noncanonical Wnt signalling pathway, which is β-cateninindependent, has also been shown to have a critical role in intestinal regeneration 119 . YAP1 and TAZ can be activated by noncanonical Wnt signalling, and many proteins induced by active YAP1 and TAZ can antagonize canonical Wnt signalling in vitro. This study provides a mechanism by which noncanonical Wnt signalling might antagonize canonical Wnt signalling through YAP1 (REF. 120 ). As a result, testing whether the effect of noncanonical Wnt signalling in intestinal regeneration is mediated by YAP1 and TAZ would be interesting. Crosstalk between Wnt and the Hippo pathway is highly complex and future investigation is needed to fully understand their interplay.
Hippo and Notch signalling. In addition to Wnt, the Notch pathway is also required to maintain ISCs. as CSL (CBF1/RBPjκ/Su(H)/Lag-1)), to induce the expression of target genes such as the HES transcription factor family, CDKN1A (also known as p21) and MYC. Pharmacological inhibition of Notch signalling in mice results in decreased expression of the stem cell markers olfactomedin 4 (Olfm4) and Lgr5 and reduced numbers of crypt base columnar stem cells 122 . Besides preserving stemness, Notch signalling is able to determine cell fate during differentiation. High Notch activity promotes the differentiation of transit amplifying cells along the absorptive lineage 123 , whereas inhibition of Notch signalling leads to loss of stem cell properties and induces secretory lineage differentiation 124 . Notch signalling is also regulated by the Hippo pathway. Mice with intestine-specific conditional double knockout of Mst1 and Mst2 have intestines with increased NICD nuclear localization and upregulated Hes1 gene expression 101 . The expansion of undifferentiated intestinal progenitor cells resulting from YAP1 overexpression in transgenic mice is attenuated when γ-secretase inhibitors that block Notch signalling are administered 98 . In summary, these data suggest that YAP1 can positively regulate Notch signalling in the intestine, and that Notch is a mediator of YAP1-induced ISC expansion. The molecular mechanism by which Hippo regulates Notch in the intestine has not yet been elucidated. Nevertheless, several members of the Notch pathway, such as Notch1 and Notch2, Sox9 and Hes1, are transcriptionally upregulated in hepatocytes with YAP1 overexpression, and Notch2 was identified as a direct target gene of the YAP1-TEAD complex 125 . This notion might provide insights into the interplay between Hippo and Notch pathways in the intestine.
Hippo and BMP signalling. Although not in the context of intestinal cells, the existence of crosstalk between Hippo and BMP signalling or between Hippo and Hedgehog signalling has also been established. BMPs regulate cellular differentiation, apoptosis and cell growth 126 . Inhibition of BMP signalling by overexpressing its antagonist Noggin in the mouse intestine results in hyperproliferation of ISCs, an increased number of crypts, and eventually intestinal polyposis 127, 128 . These data suggest that BMP signalling negatively regulates stem cell proliferation in the crypt. BMP signalling is initiated by BMP ligands binding to type I and type II serine/threonine kinase receptors. Activated receptors then phosphorylate the C-termini of SMADs (SMAD1, SMAD5, and SMAD8), which then bind to their cooperative partner SMAD4, and translocate into the nucleus 126 . This transcriptional complex of SMAD1, SMAD5, SMAD7 and SMAD4 is fully activated by phosphorylation at the linker region by cyclin-dependent kinase (CDK)8 and/or CDK9. In mouse embryonic stem cells, the phosphorylated SMAD1-SMAD4 complex recruits YAP1 to the enhancer region of BMP-responsive genes, resulting in BMP-induced gene expression 129 .
Hippo and Hedgehog signalling. Hedgehog signalling has also been implicated in intestinal homeostasis. Indian hedgehog and sonic hedgehog, two key Hedgehog signalling proteins, are expressed in mouse intestinal epithelium 130 . Ablation of Indian hedgehog protein in the mouse small intestine causes overexpansion of the stem cell niche and reduces stem cell differentiation along the absorptive lineage 131 . Although the crosstalk between Hippo and Hedgehog signalling has not been characterized in intestinal tissue, there is evidence of crosstalk between the two pathways in other tissues. For example, in medulloblastoma, cerebellar granule neuron precursors (CGNPs) are implicated as the origin of the tumours, and their proliferation depends on Sonic hedgehog signalling 132, 133 . Activation of Sonic hedgehog in CGNPs upregulates YAP1 protein levels, and direct binding between YAP1 and insulin receptor substrate 1 (IRS1), a Sonic hedgehog effector, results in nuclear localization of YAP1. In addition, YAP1 depletion abolishes Sonichedgehog-induced CGNP proliferation. GLI2, a downstream effector of Sonic hedgehog signalling, is identified as a target gene of the YAP1-TEAD complex, suggesting a mechanism by which YAP1 drives tumorigenesis in medulloblastoma 134 . However, Indian hedgehog is the predominant Hedgehog protein expressed in the gastrointestinal tract. Understanding the crosstalk between Hippo and Hedgehog signalling in the intestine, which might be mediated by Indian hedgehog, remains an interesting question and needs further exploration. In summary, the crosstalk between Hippo and other signalling pathways is complex and might be context-dependent. The Hippo pathway has been shown to communicate with the BMP pathway and the Hedgehog pathways in other biological contexts, and one can speculate that these interactions would also be present in the intestine and contribute to tissue homeostasis.
Hippo pathway in intestinal diseases
The Hippo pathway in colon cancer Uncontrolled tissue regeneration can lead to malignant transformation 135 . Dysregulation of the Hippo pathway has been observed in many cancer types 41 , including CRC. Genetically engineered mouse models serve as useful tools to study how the Hippo pathway influences tumorigenesis. Because global knockout of many genes encoding Hippo pathway components, such as Nf2, Sav1, Mst1, Mst2 and Lats2, results in embryonic lethality in mice, intestinal-epithelium-specific conditional knockout mice have been developed. Mice with conditional knockout of both Mst1 and Mst2 in the intestinal epithelium develop dysplastic small and large intestine and spontaneous adenomas in the colon 101 . The increased tumour risk might be the result of elevated YAP1 protein expression in these mice, resulting in strong activation of Wnt and Notch signalling. Intestinal-epitheliumspecific Sav1-knockout mice develop colonic polyps by 13 months of age, whereas wild-type littermates do not develop polyps 100 . This study further showed that DSSinduced intestinal injury and repair greatly exacer bated the tumorigenicity of the Sav1-deficient crypts. This effect was YAP1-dependent, as mice with intestinal epithelium-specific knockout of both Sav1 and Yap1 had no colonic polyp formation. In addition to canonical Hippo pathway components, the NDR protein kinases have been identified as tumour suppressors upstream of YAP1. Mice with intestinal epithelium-specific knockout of both Ndr1 and Ndr2 show increased YAP1 expression level and are more sensitive to colon carcinogenesis induced by DSS or azoxymethane 136 . These data support the notion that dysregulation of Hippo pathway leads to tumorigenesis and that active YAP1 is oncogenic in CRCs.
Studies of samples from patients with colon cancer and human colon-cancer-derived cell lines also support the oncogenic property of YAP1 and TAZ in CRCs. A positive correlation between YAP1 protein expression level and poor prognosis has been observed in patients with CRC 101, 137, 138 , and TAZ has also been found to be a prognostic indicator for CRC outcome 139, 140 . In human colon cancer cell lines, YAP1 knockdown by smallhairpin RNA resulted in a dramatic decrease in cell proliferation, metastasis and invasion, whereas overexpression of YAP1 resulted in an increased proliferation rate 101, 139 . Knockdown of TAZ resulted in decreased cell proliferation, both in vitro and in xenograft mouse models 141 . These studies support YAP1 and TAZ as oncogenes in CRCs.
Several underlying mechanisms of Hippo-pathwaydriven tumour transformation have been proposed. The Wnt-β-catenin pathway has a crucial role in initiating CRC. Loss of function mutations in the gene encoding adenomatous polyposis coli (APC) are observed in most colorectal tumours 142 . APC mutation increases the risk of CRC through the constitutive activation of the β-catenin-TCF4 complex in IECs 143 . Proteins encoded by β-catenin-TCF4 complex target genes, including matrilysin (also known as MMP-7), Myc, cyclin D1 and PPARδ, have been shown to contribute to CRC tumour progression [144] [145] [146] [147] [148] . YAP1 and TAZ are activated in APC-deficient cells both in vitro and in vivo 99, 117, 149 , and mouse models with intestine-specific Apc-knockout do not show intestinal hyperplasia if TAZ or YAP1 are also knocked out in the intestines 99, 149 . Different mechanisms have been proposed for how APC regulates the activity of YAP1 and TAZ. Azzolin et al. 99 reported that YAP1 and TAZ are sequestered in the cytoplasm by the β-catenin destruction complex when Wnt signalling is not active. When Wnt is activated by APC depletion, YAP1, TAZ and β-catenin separate from the destruction complex and become active. Cai et al. 149 reported that the activity of YAP1 and TAZ can also be regulated by APC via a mechanism independent of the β-catenin destruction complex. They showed that APC serves as a scaffolding protein to facilitate LATS activation. Loss of APC inactivates the Hippo pathway, leading to YAP1 and TAZ activation 149 . Other studies have shown that the β-catenin-TCF4 complex directly binds to the YAP1 enhancer region to promote YAP1 gene expression, thereby identifying YAP1 as a TCF4 target gene 118 . In addition, β-catenin can complex with YAP1 and TBX5 to induce anti-apoptotic gene expression; this complex is essential for survival of β-catenin-driven colon cancers 150 . Together, these results suggest that YAP1 and TAZ can be mediators downstream of APC, and that their activities contribute to colonic tumorigenesis. The dispensable nature of YAP1 and TAZ under normal conditions make them an attractive therapeutic target for treating CRC.
In addition to Wnt signalling, JNK signalling has also been implicated in inducing tumorigenesis in the intestine 151, 152 . Several studies indicate that JNK is an upstream regulator of the Hippo pathway. In the Drosophila midgut, bleomycin-induced injury activates JNK, leading to Yki nuclear translocation. Activated Yki upregulates Upd expression and Jak-Stat signalling, which induces cellular proliferation 25, 153 . In mammals, JNK induces YAP1 activity when cells are exposed to mechanical strain 66 and DNA damage 154 . Mechanistically, JNK activates YAP1 through inhibition of LATS by increasing binding between LATS proteins and Ajuba (the mammalian homologue of Jub) 80 . Although no studies have established a connection between JNK signalling and the Hippo pathway in the context of the mammalian intestine, this mechanism could be worthy of further exploration in colorectal tumorigenesis.
The Hippo pathway in other intestinal diseases
Peutz-Jeghers syndrome (PJS) is characterized by the development of benign polyps in the gastrointestinal tract. In PJS, the tumour suppressor LKB1 is frequently mutated, leading to intestinal polyp formation 155 . These polyps can cause bleeding, bowel obstructions and pain. Patients with PJS are at an increased risk of developing various cancers, especially gastrointestinal tumours 156, 157 . The polyps in these patients were observed to exhibit increased YAP1 nuclear localization, prompting the investigation of the connection between LKB1 and the Hippo pathway. As a result, LKB1 has been identified as an upstream regulator of Hippo signalling. In vitro studies show that loss of LKB1 leads to YAP1 nuclear localization in intestinal epithelial cell lines, and depleting YAP1 expression reduces cancer phenotypes, including decreasing cell proliferation rate, colony formation and tumour size 49, 158 . In addition, LKB1 is a major positive upstream regulator of AMPK activity. Activated AMPK inhibits YAP1 through several mechanisms, including: activation of LATS proteins; direct phosphorylation of YAP1 at serine 94, disrupting YAP1 interaction with TEAD proteins; and stabilizing Angiomotin-like protein 1 (AMOTL1), which inhibits YAP1 (REFS 50,52). Loss of LKB1 might contribute to tumorigenesis by lowering AMPK activity, resulting in YAP1 hyperactivation.
IBD, including Crohn's disease and ulcerative colitis, is a chronic idiopathic inflammatory disorder that affects the gastrointestinal tract. Appropriate intestinal epithelial regeneration is required to improve the outcomes of treatments for IBD. YAP1 regulation has been identified as a responsive mechanism for mucosal regeneration in IBD using a DSS-induced colitis mouse model 100, 108 . IL-6 is a key modulator of the intestinal inflammatory response that can promote intestinal epithelial cell prolifer ation and regeneration 159 . As mentioned earlier, gp130 activates YAP1 upon DSS treatment. Villin-gp130 Act mice, which express constitutively active gp130 exclusively in IECs, have increased YAP1 nuclear localiza tion, and IEC-specific Yap1 depletion in gp130
Act mice reverses their DSS resistance 108 . This study establishes a mechanism by which YAP1 is activated upon intestinal injury and provides insights into potential therapeutic strategies for IBD.
The Hippo pathway in the liver
The liver is the central organ controlling metabolism of carbohydrates, lipids and amino acids, as well as detoxification of both exogenous and endogenous compounds 160 . The liver is capable of rapidly renewing its parenchymal cells (hepatocytes) and non-parenchymal cells (cholangiocytes, Kupffer cells, stellate cells and sinusoidal endothelial cells) after injury to resume its physiological functions 161 .
Regulation of liver size by Hippo signalling
Liver regeneration and homeostasis are considered a classic model for mammalian organ size control 162 . The discovery that Hippo signalling is essential in the regulation of tissue homeostasis in Drosophila was followed immediately by speculation over whether the Hippo pathway similarly regulates mammalian organ size 163 . In mammalian models, overexpression of YAP1 in the liver leads to tissue overgrowth, and sustained overexpression of YAP1 eventually results in hepatocellular carcinogenesis 39, 98 . In human hepatocellular carcinoma specimens, high YAP1 protein levels and increased YAP1 nuclear localization have been observed 36, 39, 164 . Because liver cancer results from uncontrolled proliferation of hepatocytes, increased YAP1 expression in human liver cancer and mouse models supports the notion that YAP1 can serve as a major driver of hepatocyte proliferation. Mouse models bearing deletion of Hippo pathway proteins, including MST1, MST2, SAV1, Merlin, LATS1 and LATS2, have been generated and characterized for the roles of these components in liver size control and carcinogenesis 106, [165] [166] [167] [168] [169] (FIG. 6) . Hepatomegaly and spontaneous hepatocellular carcinogenesis were consistently observed in liver-specific Mst1 and Mst2 knockout mice [165] [166] [167] [168] . Liver-specific Sav1-knockout mice exhibit more complex tumorigenesis, and display both hepato cellular carcinoma and cholangiocarcinoma 165, 168 . SAV1-deficient mice have been speculated to be more prone to the malignant transformation of liver progenitor cells than wild-type mice, whereas hepatocytes are unaffected by loss of SAV1 (REF. 165 ). Similarly, liverspecific Nf2-knockout mice develop hepato cellular carcinoma and bile duct hamartoma at 1 year of age 169 . A study published in 2013 showed that combined liverspecific deletion of Nf2 and Sav1 causes an exaggerated liver overgrowth phenotype in mice at a very early age (8 days old), whereas deletion of either Nf2 or Sav1 alone did not result in any abnormality in liver at that age 170 . This result indicates the synergistic actions of Merlin and SAV1 attenu ate YAP1 and TAZ activity during liver development. Consistently, mice with knockout of other Hippo pathway components, such as Mob1a and Mob1b, also induce spontaneous hepatocellular carcinogenesis 171 (FIG. 6) .
The role of Hippo signalling in liver development is further supported by evidence that the level of nuclear YAP1 correlates with cyclin D1 expression and hepatocyte proliferation during postnatal development in mice 172 . Mice with liver-specific Yap1 deficiency have smaller livers and a reduced hepatocyte proliferation rate compared with wild-type mice 169 . In addition, liver-specific Yap1-knockout mice show impaired bile duct formation, suggesting a critical role for YAP1 in bile duct development 169 . A study published in 2015 found that the Hippo pathway might be a major downstream effector of the transcription factors SOX4 and SOX9, which regu late liver and bile duct development 173 . Another study published in 2014 showed that the main function of the Hippo pathway in the liver is to maintain the differentiation status of hepatocytes 125 . The activation of YAP1 dedifferentiates adult mouse hepatocytes into progenitor or ductal-like cells. In summary, YAP1 induces cell proliferation and suppresses differentiation during liver development, and reduced Hippo pathway activity causes uncontrolled organ growth and therefore tumorigenesis.
Hippo signalling is also involved in liver repair after injury in mouse models. A few studies have implicated that the Hippo signalling regulates liver regeneration after partial hepatectomy in rats and mice [174] [175] [176] . In addition, studies in the past few years have demonstrated the essential role of YAP1 in liver repair after injury. Deletion of Yap1 in mice potentiates cholestatic liver injury caused by bile-duct ligation 144 . Similarly, mice with liver-specific knockout of Yap1 exhibit deficient liver repair after carbon-tetrachloride-induced liver injury 177 . Notably, this study used a mosaic knockout mouse model to show that YAP1 activation alone in a fraction of hepatocytes is not sufficient to drive growth of the liver, whereas previous reports showed an organ hyperplasia phenotype as a result of YAP1 overexpression in the entire liver 39, 98 . A possible explanation for this finding is that relative YAP1 activation in the two models is different. In conjunction with high YAP1 activity, inflammatory signals, which are always present in the context of liver injury, are essential to induce prolifer ation of hepatocytes 177 . Upon liver injury, YAP1 is also activated in cells besides hepatocytes. In the livers of carbon-tetrachloride-treated mice and tissue samples from human fibrotic livers, activated YAP1 causes activation of hepatic stellate cells. Prolonged activation of these cells leads to liver fibrogenesis 178 .
Hippo signalling and human liver tumorigenesis
In the healthy adult liver, YAP1 is expressed and active in the bile duct cells, whereas it is expressed at low levels and is inactive in hepatocytes 125 . However, numerous immunohistochemistry and immunoblot analyses show raised YAP1 protein levels and increased nuclear localization in human liver cancer cells compared with adjacent normal tissues 36, 39, 164, [179] [180] [181] [182] . YAP1 activity, defined either as protein levels or the degree of nuclear localization, can serve as a prognostic marker for overall survival and disease-free survival of patients with hepatocellular carcinoma 164, 183 . YAP1 activation in liver cancer could result from many factors. The YAP1 gene was observed to be frequently amplified in human hepatocellular carcinoma tumours 184 . YAP1 can also be activated by carcinogenic compounds such as 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene 185 , which mimics the xenobiotic phenobarbital to activate the nuclear receptor constitutive androstane receptor (CAR). The tumour-promoting role of CAR has already been implicated in liver cancer 186, 187 . However, a direct link between YAP1 and CAR has not been clearly established. HBV is a major cause of liver cancer, and the viral HBx protein can increase hepatocyte protein levels of YAP1 and TAZ in vitro, which might contribute to tumorigenesis induced by HBV infection 188, 189 . In addition, bile acids, which play an important regulatory part in liver injury and injuryrelated carcinogenesis 190, 191 , also activate YAP1 to promote spontaneous liver tumorigenesis in a mouse model of hepatocellular carcinoma 192 . Mechanistically, the tumour-promoting property of YAP1 in liver cancer mainly relies on TEAD-mediated gene transcription. The YAP-TEAD complex can upregulate the expression of genes directly involved in promoting cell proliferation and tissue overgrowth, for instance the Notch ligand Jagged1 and the amino acid transporters SLC38A1 and SLC7A5 (REFS 193, 194) . In addition, YAP-TEAD also increases expression of the microRNA miR-130a, which in turn activates YAP1 by repressing the translation of the YAP1 antagonist VGLL4, resulting in a positive feedback loop that reinforces TEAD-mediated transcription 195 . Using gene-set enrichment analysis of liver tissue from a mouse model of liver cancer, a study published in 2015 reported that the YAP-TEAD complex colocalizes with other transcription factors, such as E2F1, HNF4α and β-catenin, to coordinate the expression of genes that modulate hepatocyte quiescence and differentiation 196 . Disruption of YAP-TEAD interaction using verteporfin abolishes tumour growth in vitro and in mouse models 74, 197 ; targeting YAP-TEAD interaction could therefore be a potential therapeutic strategy for hepatocellular carcinoma. 
Conclusions
The Hippo pathway has an important role in intestinal homeostasis and regeneration in both Drosophila and mammals, and its dysregulation often leads to tumorigenesis. In general, YAP1 and TAZ activity is associated with ISC maintenance and progenitor cell prolifer ation. Although YAP1 and TAZ might be dispens able under normal intestinal homeostasis, their activation is crucial during tissue regeneration, particularly in response to injury. Negative regulation of YAP1 and TAZ activity by upstream components of the Hippo pathway, such as MST1, MST2 and SAV1, is required to maintain normal intestine homeostasis and prevent tissue overgrowth. The Hippo pathway is integrated with other key pathways that are important for intesti nal homeostasis, such as the Wnt signalling pathway. YAP1 acts either as a downstream effector and/or an inhibitor of Wnt signalling to contribute to ISC mainten ance and differentiation of transit amplify ing cells. The complex communications between the Hippo pathway and other pathways, especially the Wnt pathway, are still being explored and remain an important question in the gastro intestinal field. Notably, in vitro studies show the Hippo pathway can be activated by tight junctions and adherence junctions. Intestinal diseases are often associ ated with disruption of the intestine lining and junction structures. One can specu late that the intactness of IEC junction structure is a major signal acting via the Hippo pathway to modulate intestine homeo stasis. Thus, it would be interesting to investigate the regulation of the Hippo pathway by junctions in the intestine, and how the junction structures contrib ute to intestinal tissue regeneration in the context of Hippo signalling pathway.
